Chronic Condition Management

Physicians have a role in stamping out weight bias.

Could be new challenge for Social Security, analyst says

May stop cycle of inflammation that can lead to diabetes and depression

Over-medicating may lead to adverse drug interactions and make their dementia worse

How to overcome the rising costs of obesity

Pending FDA approval, could be available in 2024.

Rural areas lag well behind their urban counterparts when it comes to COVID-19 vaccinations

The results are published online in Clinical Infectious Diseases.

The CDC is seeking comment on the voluntary guidelines, which come on the heels of the controversial 2016 guidance that placed hard caps on prescribing.

Big pharma and investors focusing on other segments despite the need for new therapeutics

These drugs treat everything from cancer to cognitive decline.

Apretude is approved for use in at-risk adults and adolescent to reduce the risk of sexually acquired HIV.

Blood clot risk in J&J higher for women, draws CDC concerns

Sanjay Rajagopalan, MD, the Herman K. Hellerstein, MD, chair in cardiovascular research at University Hospitals of Cleveland Harrington Heart & Vascular Institute, discusses the link between cardiovascular disease and air pollution and how primary care doctors can help patients lower their risk of cardiovascular disease caused by air pollution.

Identifying and assisting patients with social determinants is challenging, but can boost outcomes

Women and those in their 50s and early 60s reported the most stress about COVID

PreHevbrio is the only 3-antigen vaccine for Hepatitis B approved for adults

Is more testing the answer to a worsening drug crisis?

The "Cures 2.0" bill, if signed into law, would expand medical research, aid development of new therapies and expand telehealth.

The product is the first interchangeable insulin biosimilar approved by the FDA.

Healthcare staffing shortages exacerbated by the COVID-19 pandemic have intensified an already serious problem in healthcare: clinician burnout.

Until now, measures to prevent cardiovascular diseases have focused almost entirely on individual behavioral and metabolic risk factors.

How medical practices can create effective vaccination programs for the months ahead

As we move beyond COVID-19, The healthcare industry is just beginning to uncover the impact of delayed cancer screenings and care on oncology outcomes.